Medications for Opioid Use Disorder (MOUD) Improve Short-term Residential OUD Treatment Completion and Retention
Medications for Opioid Use Disorder (MOUD) Improve Short-term Residential OUD Treatment Completion and Retention
Little is known about the impact of medications for opioid use disorder (MOUD) on residential OUD treatment outcomes. Researchers extracted data from a US national dataset of admissions and discharges from publicly funded substance use disorder treatment facilities. Data from adults admitted to either a short-term (ST; <30 days) or long-term (LT; >30 days) OUD residential treatment center between 2015 and 2017 were assessed to determine the effects of MOUD on the probability of treatment completion and retention (defined as a stay >10 days or >90 days for ST and LT treatment, respectively). Alcohol, Other Drugs, and Health: Current Evidence, USA, März-April 2021)
http://www.bu.edu/aodhealth/2021/04/29/medications-for-opioid-use-disorder-moud-improve-short-term-residential-oud-treatment-completion-and-retention/